Evidence map›Paper›PMID 39329962›Full record

ArticleCurrent issues in molecular biology2024

mRNA Fragmentation Pattern Detected by SHAPE.

Shanshan Feng, Ting Chen, Yunlong Zhang, Changrui Lu

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shanshan FengCollege of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
Ting ChenCollege of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
Yunlong ZhangCollege of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
Changrui LuCollege of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.

Funding

Foundation of Shanghai Science and Technology Committee 19410711000Medicine-Engineering Interdisciplinary Project of Shanghai Xuhui District Dental Center SHXYFYG202304Shanghai Science and Technology Commission grant 19410741800
6 · The paper itself

Abstract

The success of messenger RNA (mRNA) vaccines in controlling COVID-19 has warranted further developments in new technology. Currently, their quality control process largely relies on low-resolution electrophoresis for detecting chain breaks. Here, we present an approach using multi-primer reverse transcription sequencing (MPRT-seq) to identify degradation fragments in mRNA products. Using this in-house-made mRNA containing two antigens and untranslated regions (UTRs), we analyzed the mRNA completeness and degradation pattern at a nucleotide resolution. We then analyzed the sensitive base sequence and its correlation with the secondary structure. Our MPRT-seq mapping shows that certain sequences on the 5' of bulge-stem-loop structures can result in preferential chain breaks. Our results agree with commonly used capillary electrophoresis (CE) integrity analysis but at a much higher resolution, and can improve mRNA stability by providing information to remove sensitive structures or sequences in the mRNA sequence design.

Indexed as

degradationfreeze–thaw cycleslong-term storagemRNA stabilitymRNA structure

Identifiers

PMID39329962
PMCPMC11431040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.